Table 1.
Composition and formulation of supplements used in the study
| Nutrient | Chemical form used in supplement formulation | IFA | MMN | SQ-LNSa |
|---|---|---|---|---|
| Ration (g/day) | 1 tablet | 1 tablet | 20 | |
| Total energy (kcal) | 0 | 118 | ||
| Protein (g) | 0 | 2.6 | ||
| Fat (g) | 0 | 10 | ||
| Linoleic acid (g) | 0 | 4.59 | ||
| α-Linolenic acid (g) | 0 | 0.59 | ||
| Vitamin A (μg RE) | Retinyl acetate | 800 | 800 | |
| Vitamin C (mg) | l-ascorbic acid | 100 | 100 | |
| Vitamin B1(mg) | Thiamin hydrochloride | 2.8 | 2.8 | |
| Vitamin B2 (mg) | Riboflavin | 2.8 | 2.8 | |
| Niacin (mg) | Niacinamide | 36 | 36 | |
| Folic acid (μg) | Pteroyl monoglutamic acid | 400 | 400 | 400 |
| Pantothenic acid (mg) | Calcium pantothenate | 7 | 7 | |
| Vitamin B6 (mg) | Pyridoxine hydrochloride | 3.8 | 3.8 | |
| Vitamin B12 (μg) | Cyanocobalamin (0.1%) | 5.2 | 5.2 | |
| Vitamin D (IU) | Cholecalciferol (D3) | 400 | 400 | |
| Vitamin E (mg) | dl-alpha-tocopherol acetate | 20 | 20 | |
| Vitamin K (μg) | Phylloquinone 5% | 45 | 45 | |
| Iron (mg) | Encapsulated ferrous sulphate | 60 | 20 | 20 |
| Zinc (mg) | Zinc sulphate | 30 | 30 | |
| Copper (mg) | Encapsulated copper sulphate | 4 | 4 | |
| Calcium (mg) | Tricalcium phosphate | 0 | 280 | |
| Phosphorus (mg) | Tricalcium phosphate | 0 | 190 | |
| Dipotassium phosphate | ||||
| Potassium (mg) | Potassium chloride | 0 | 200 | |
| Dipotassium phosphate | ||||
| Magnesium (mg) | Magnesium citrate | 0 | 65 | |
| Selenium (μg) | Sodium selenite 1.5% | 130 | 130 | |
| Iodine (μg) | Potassium iodate | 250 | 250 | |
| Manganese (mg) | Manganese sulphate | 2.6 | 2.6 |
Information from table previously published from Adu-Afarwuah et al. (2015) and Arimond et al. (2013)
IFA iron and folic acid capsule, MMN multiple micronutrient supplement capsule, SQ-LNS small-quantity lipid-based nutrient supplement for pregnant and lactating women
aNutrient concentrations include contributions from the ingredients as well as from the multiple micronutrient premix